3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
19
Recurrence
5
Sarcoma, Kaposi
2
Neoplasms
2
Acquired Immunodeficiency Syndrome
2
Plasmacytoma
1
Plasmablastic Lymphoma
1
Neoplasms, Plasma Cell
1
Multi-centric Castleman's Disease
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Epstein-Barr Virus Infections
1
Burkitt Lymphoma
1
Interventions
venetoclax
28
Cytarabine
25
Azacitidine
23
Specimen Handling
21
fludarabine
15
Biopsy
13
Injections
12
Daunorubicin
11
Cyclophosphamide
11
fludarabine phosphate
10
decitabine and cedazuridine drug combination
9
Whole-Body Irradiation
9
CPX-351
8
Mycophenolic Acid
7
Idarubicin
7
Granulocyte Colony-Stimulating Factor
7
Gemtuzumab
7
ivosidenib
6
Tacrolimus
6
Stem Cell Transplantation
6
Filgrastim
6
Busulfan
6
enasidenib
5
X-Rays
5
Melphalan
5
Etoposide
5
Decitabine
5
Cyclosporine
5
ruxolitinib
4
olutasidenib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Acute
×
pomalidomide
×
30 days
×
Clear all
No trials found.